+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cystic Fibrosis Market by Product Type, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030- Product Image
Cystic Fibrosis Market by Product Type, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Cystic Fibrosis Market by Product Type, Route Of Administration, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084162
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cystic fibrosis management is seeing rapid transformation as innovations in precision medicine, gene-focused therapeutics, and digital health set new standards for care. For senior decision-makers, understanding this evolving market is crucial for aligning product strategy, regulatory planning, and stakeholder engagement to capture emerging opportunities and drive sustainable growth.

Market Snapshot: Cystic Fibrosis Market Overview

The cystic fibrosis market is entering a period of robust expansion, shaped by significant breakthroughs in genetic therapies and the increasing adoption of digital health technologies. The market is projected to grow steadily, supported by advancements in CFTR modulator treatments and broader access to specialized healthcare services. Key drivers include evolving regulatory guidelines, growing investment in research and development, and shifting payer landscapes that emphasize value-based contracting. The interplay of novel product launches, increasing patient awareness, and strategic collaborations is redefining the competitive landscape, fostering innovation across the entire care spectrum. As stakeholders navigate this dynamic environment, the focus remains on enhancing patient quality of life, optimizing therapy outcomes, and expanding access while addressing ongoing reimbursement and infrastructure challenges.

Scope & Segmentation

This comprehensive analysis enables leaders to identify and act on pivotal opportunities across multiple dimensions. The report provides clear segmentation and actionable insights, supporting informed decisions around investment, partnership, and market entry strategies.

  • Product Types: Anti-inflammatories, antibiotics, CFTR modulator therapies (including elexacaftor tezacaftor ivacaftor, ivacaftor, lumacaftor ivacaftor, tezacaftor ivacaftor), mucolytics, pancreatic enzymes.
  • Route of Administration: Inhalation, intravenous, oral therapies enable tailored delivery based on patient and care setting needs.
  • Distribution Channels: Hospital pharmacies play a vital role in acute care initiation; online pharmacies support refill management and remote delivery; retail pharmacies enhance patient education and product uptake.
  • End Users: Home healthcare settings support self-administered therapies, hospitals address acute incidents, and specialty clinics focus on precision dosing and multidisciplinary support.
  • Regions: Coverage includes the Americas (with deep dives on United States, Canada, Brazil, and others), Europe, Middle East, & Africa (covering major national health systems), and Asia-Pacific (including China, India, Japan, and key markets).
  • Technologies: Market assessment spans CFTR modulator advances, gene editing and mRNA therapeutics, digital health integration (patient monitoring, telemedicine), and differentiated dosing platforms for various population needs.

Key Takeaways for Senior Decision-Makers

  • Precision medicine and genetic therapies are fundamentally changing the cystic fibrosis treatment paradigm, focusing on root-cause correction rather than symptom management.
  • Integrated digital health platforms and data-driven care models are elevating patient engagement, adherence, and monitoring, enabling personalized therapeutic decisions and real-time optimization.
  • Collaborative alliances among biopharma, biotech, payers, and advocacy organizations accelerate translational research and foster broader market access strategies.
  • Product segmentation reveals that while anti-inflammatories and antibiotics remain core, advanced CFTR modulators are now driving primary market expansion.
  • Supply chain resilience, robust scenario planning, and early regulatory engagement are vital for mitigating risk, especially in light of shifting global trade policy and reimbursement models.
  • Tailored commercial strategies by care setting and region improve uptake, as home healthcare grows in prominence for chronic care while specialty clinics build expertise in new therapeutic modalities.

Tariff Impact on the Cystic Fibrosis Market

Recent U.S. tariff reforms have introduced substantial volatility into active pharmaceutical ingredient sourcing and finished drug pricing. These changes have led manufacturers to re-evaluate procurement strategies, shift towards onshore production, and enter longer-term supply agreements to manage cost fluctuations. Payer organizations and pharmacy benefit managers have adapted by redesigning formularies, often transferring higher expenses to patients or adjusting access programs. Larger specialty drug providers have generally absorbed costs to maintain continuity, whereas smaller firms experience margin pressures, underscoring the importance of proactive market surveillance and regulatory alignment to sustain patient access and profitability.

Methodology & Data Sources

This report is grounded in direct interviews with clinicians, payers, and executive leaders, supplemented by peer-reviewed publications, regulatory files, and company disclosures. Quantitative and qualitative data were triangulated and market segmentation was validated using analytics from prescription datasets and regional registries. Throughout, strict industry standards in confidentiality and transparent reporting were maintained for reliability.

Why This Report Matters

  • Supports informed strategic planning by providing detailed, actionable segmentation and competitor analysis across major regions and care settings.
  • Enables evidence-based product positioning by highlighting the adoption patterns of innovative therapies, digital health integration, and regional infrastructure development.
  • Empowers stakeholders to anticipate evolving risks—such as tariff impacts—and turn regulatory shifts into sustainable growth opportunities.

Conclusion

The cystic fibrosis market is poised for dynamic growth as innovation, collaboration, and strategic adaptability reshape the landscape. Forward-looking organizations can harness these insights to unlock value, future-proof market access, and deliver transformative therapies to patients worldwide.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cystic Fibrosis Market, by Product Type
8.1. Introduction
8.2. Anti Inflammatories
8.3. Antibiotics
8.4. Cftr Modulator Therapy
8.4.1. Elexacaftor Tezacaftor Ivacaftor
8.4.2. Ivacaftor
8.4.3. Lumacaftor Ivacaftor
8.4.4. Tezacaftor Ivacaftor
8.5. Mucolytics
8.6. Pancreatic Enzymes
9. Cystic Fibrosis Market, by Route Of Administration
9.1. Introduction
9.2. Inhalation
9.3. Intravenous
9.4. Oral
10. Cystic Fibrosis Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Cystic Fibrosis Market, by End User
11.1. Introduction
11.2. Home Healthcare
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Cystic Fibrosis Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cystic Fibrosis Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cystic Fibrosis Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Vertex Pharmaceuticals Incorporated
15.3.2. F. Hoffmann-La Roche Ltd
15.3.3. Novartis AG
15.3.4. Gilead Sciences, Inc.
15.3.5. Teva Pharmaceutical Industries Ltd
15.3.6. Viatris Inc.
15.3.7. Sandoz International GmbH
15.3.8. Sun Pharmaceutical Industries Ltd
15.3.9. Cipla Limited
15.3.10. Lupin Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CYSTIC FIBROSIS MARKET MULTI-CURRENCY
FIGURE 2. CYSTIC FIBROSIS MARKET MULTI-LANGUAGE
FIGURE 3. CYSTIC FIBROSIS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CYSTIC FIBROSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CYSTIC FIBROSIS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CYSTIC FIBROSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ELEXACAFTOR TEZACAFTOR IVACAFTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY IVACAFTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY LUMACAFTOR IVACAFTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY TEZACAFTOR IVACAFTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. CANADA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 43. CANADA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. CANADA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 69. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 74. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 79. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. ITALY CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. ITALY CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 89. ITALY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. ITALY CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. ITALY CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 94. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 104. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 109. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 114. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. DENMARK CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 119. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. QATAR CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. QATAR CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 124. QATAR CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. QATAR CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. QATAR CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 129. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. FINLAND CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 144. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. EGYPT CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. TURKEY CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. TURKEY CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 149. TURKEY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. TURKEY CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. TURKEY CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. NORWAY CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. NORWAY CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 159. NORWAY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. NORWAY CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. NORWAY CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. POLAND CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. POLAND CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 164. POLAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. POLAND CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. POLAND CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SWITZERLAND CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 169. SWITZERLAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 178. CHINA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. CHINA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 180. CHINA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. CHINA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. CHINA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. INDIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. INDIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 185. INDIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. INDIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. INDIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 190. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 210. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN CYSTIC FIBROSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATOR THERAPY, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN CYSTIC FIBROSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN CYSTIC FIBROSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. CYSTIC FIBROSIS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 239. CYSTIC FIBROSIS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cystic Fibrosis market report include:
  • Vertex Pharmaceuticals Incorporated
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Gilead Sciences, Inc.
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd
  • Cipla Limited
  • Lupin Limited

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.14 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cystic Fibrosis Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Pancreatic Enzyme Supplements), Route of Administration (Oral), Distribution Channel, Region, and Segment Forecasts, 2025-2030 - Product Image

Cystic Fibrosis Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Pancreatic Enzyme Supplements), Route of Administration (Oral), Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • Report
  • 90 Pages
  • Global
From
Cystic Fibrosis (CF) Therapeutics Market Report 2025 - Product Image

Cystic Fibrosis (CF) Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cystic Fibrosis Therapeutics Market Report by Drug Class, Drug Molecule Type, Route of Administration, End-User, and Region 2024-2032 - Product Image

Cystic Fibrosis Therapeutics Market Report by Drug Class, Drug Molecule Type, Route of Administration, End-User, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
Cystic Fibrosis Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Cystic Fibrosis Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 92 Pages
  • Global
From
Cystic Fibrosis Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Cystic Fibrosis Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Cystic Fibrosis Drug Market

The Cystic Fibrosis Drug market is a subset of the larger Respiratory Drug market. It is composed of treatments and therapies designed to address the symptoms of cystic fibrosis, a genetic disorder that affects the lungs and digestive system. These drugs are used to reduce the amount of mucus in the lungs, improve breathing, and reduce the risk of infection. They may also be used to treat other symptoms, such as malnutrition, dehydration, and vitamin deficiencies. The Cystic Fibrosis Drug market is highly competitive, with many companies developing and marketing treatments. Some of the major players in the market include Vertex Pharmaceuticals, Gilead Sciences, Novartis, and GlaxoSmithKline. Other companies, such as AbbVie, Merck, and Pfizer, are also active in the market. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.